Kabeer Aziz

Insider Reports History

Location
376 Manhattan Avenue Apt. 3, Brooklyn, NY
Signature
/s/ Lucy Day, Attorney-in-Fact for Kabeer Aziz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kabeer Aziz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Director Common Stock 378K $479K $1.27 Oct 10, 2025 Indirect
AN2 Therapeutics, Inc. Director Common Stock 40.9K $52K $1.27 Oct 10, 2025 Direct
AN2 Therapeutics, Inc. Director Stock Optin (Right to Buy) 19.1K May 22, 2025 Direct

Insider Reports Filed by Kabeer Aziz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Oct 10, 2025 1 $0 4 Oct 14, 2025 Director
ANTX AN2 Therapeutics, Inc. Jul 10, 2025 1 $0 4 Jul 11, 2025 Director
ANTX AN2 Therapeutics, Inc. May 22, 2025 1 $0 4 May 23, 2025 Director
ANTX AN2 Therapeutics, Inc. Apr 10, 2025 1 $0 4 Apr 11, 2025 Director
ANTX AN2 Therapeutics, Inc. Dec 19, 2024 1 $0 4 Dec 23, 2024 Director
ANTX AN2 Therapeutics, Inc. Jun 19, 2024 1 $0 4 Jun 21, 2024 Director
ANTX AN2 Therapeutics, Inc. Jan 16, 2024 2 -$1.97M 4 Jan 18, 2024 Director
ANTX AN2 Therapeutics, Inc. Nov 14, 2023 2 -$29.2K 4 Nov 16, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Sep 29, 2023 4 -$1.7M 4 Oct 3, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Sep 27, 2023 4 -$151K 4 Sep 29, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 23, 2023 2 -$6.4K 4 Sep 15, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 23, 2023 4 -$114K 4 Sep 8, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 23, 2023 2 -$6.4K 4 Aug 25, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Jun 6, 2022 2 $0 4 Jun 24, 2022 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
ANTX AN2 Therapeutics, Inc. Mar 29, 2022 9 $2.5M 4 Mar 31, 2022 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3 Mar 24, 2022 Director